Clinical Trials Browser

Phase 2 × INDUSTRY × ripretinib × Clear all

NCT04633122 2025-02-10

A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib

Phase 2 Completed

108 enrolled 11 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors